WHAT WE OFFER
Public policy is an area of primary involvement for SAMCEDA in its advocacy and leadership efforts. Focusing on national, state, regional and local legislation and policy initiatives, SAMCEDA’s broad, pro-business based approach provides for informed perspective and action on critical policy issues.
For Over a Half Century...
SAMCEDA Has Worked in Partnership with…
Business, Elected Leaders, Educators, Labor, Non-Profits and many others
to promote San Mateo County as THE PLACE to live, work and prosper...
In the words of 2011 Peninsula Structures Attendees
"Heart of Bay Area Business/Innovation/Environment"
"Centralia - The Hub to get things done,
to connect to the world, the center…"
"A place of opportunity where diverse communities welcome diverse ideas"
"Modern, yet traditional. Brilliant, caring,
mind-blowing creativity, risk takers..."
"Collaborative - a history of cooperation"
"From the coast to the bay, the place to work and play..."
"San Mateo County - it's all about quality-people, business, place, education, environment..."
"Innovation lives here"
"Energy magnet for businesses and families"
"Climate for change"
Friday, December 6, 2013, 7:45- 10:15am Oracle Conference Center 350 Oracle Parkway, Redwood City More Info
Members and Partners Corner
Kathleen Sakamoto, MD, PhD, and Irving Weissman, MD, of the Stanford University School of Medicine and Lucile Packard Children’s Hospital (a member of SAMCEDA), have received a $1.37 million grant from CureSearch for Children's Cancer to research the effects of an antibody that has been shown to be effective against human cancers in animal models.
In a healthy person, when the body makes abnormal cells or when cells become old, the body's scavenger cells, called macrophages, eliminate them. When a person has cancer, the abnormal cells are not eliminated by the macrophages. Researchers under the leadership of Weissman, director of the Institute of Stem Cell Biology and of the Ludwig Center at Stanford, discovered that pediatric brain tumor, leukemia, bone tumor and neuroblastoma cells overproduce a cell-surface protein known as CD47. The overproduction of CD47 on cancer cells tells macrophages "don't eat me," allowing the disease to progress. Weissman's team tested an antibody to block the "don't eat me" signal in a variety of cancer cells and in animals and found that the strategy can be effective.
This grant will support our team’s efforts to learn more about the immune systems of pediatric cancer patients,” says Sakamoto, the Shelagh Galligan Professor and chief of the division of hematology and oncology, “and help pave the way toward our goal of developing new treatments for some of our most vulnerable patients.”To view press Release, click here
Health Law Guide for Business Launches Spanish Website
The health care law may appear large and complex, but it will provide more options for small businesses to better afford health insurance. Learn about your options, make informed decisions, and maximize your benefits.